REGENXBIO (RGNX) reported new, positive interim data from two additional patients in the Phase I/II portion of the AFFINITY DUCHENNE trial of ...

FOXO Technologies (FOXO) has signed a non-binding agreement to acquire Vector Biosource. Vector is an information and biospecimen sourcing ...